Gemella
Genus of bacteria
Gemella is a genus of Gram-positive bacteria that are part of the normal flora of the human oral cavity, upper respiratory tract, and gastrointestinal tract. The genus was first described in 1960 by Berger. The name "Gemella" is derived from the Latin word for "twin" or "paired," reflecting the characteristic appearance of these bacteria, which often occur in pairs.
Characteristics[edit]
Gemella species are facultative anaerobes, meaning they can grow in both the presence and absence of oxygen. They are non-motile and do not form spores. These bacteria are typically cocci (spherical) and can appear in pairs, short chains, or clusters. They are catalase-negative, which helps differentiate them from other Gram-positive cocci such as Staphylococcus.
Species[edit]
The genus Gemella includes several species, some of which are:
Clinical Significance[edit]
While Gemella species are generally considered part of the normal human flora, they can be opportunistic pathogens. They have been implicated in various infections, including endocarditis, bacteremia, meningitis, and osteomyelitis. Infections are more likely to occur in individuals with underlying health conditions or compromised immune systems.
Diagnosis and Treatment[edit]
Diagnosis of Gemella infections typically involves microbiological culture and molecular methods such as PCR (Polymerase Chain Reaction). Treatment usually involves antibiotics, with the choice of antibiotic depending on the specific species and its antibiotic susceptibility profile. Commonly used antibiotics include penicillin, amoxicillin, and vancomycin.
Related Pages[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian